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A B S T R A C T
Question: Among people who are hospitalised for community-acquired pneumonia, does an inpatient
exercise-based rehabilitation program improve functional outcomes, symptoms, quality of life and
length of hospital stay more than a respiratory physiotherapy regimen? Design: Randomised trial with
concealed allocation, intention-to-treat analysis and blinding of some outcomes. Participants: Forty-
nine adults hospitalised for community-acquired pneumonia. Intervention: The experimental group
(n = 32) underwent a physical training program that included warm-up, stretching, peripheral muscle
strength training and walking at a controlled speed for 15 minutes. The control group (n = 17)
underwent a respiratory physiotherapy regimen that included percussion, vibrocompression,
respiratory exercises and free walking. The intervention regimens lasted 8 days. Outcome measures:
The primary outcome was the Glittre Activities of Daily Living test, which assesses the time taken to
complete a series of functional tasks (eg, rising from a chair, walking, stairs, lifting and bending).
Secondary outcomes were distance walked in the incremental shuttle walk test, peripheral muscle
strength, quality of life, dyspnoea, lung function, C-reactive protein and length of hospital stay. Measures
were taken 1 day before and 1 day after the intervention period. Results: There was greater
improvement in the experimental group than in the control group on the Glittre Activities of Daily Living
test (mean between-group difference 39 seconds, 95% CI 20 to 59) and the incremental shuttle walk test
(mean between-group difference 130 m, 95% CI 77 to 182). There were also signiﬁcantly greater
improvements in quality of life, dyspnoea and peripheral muscle strength in the experimental group
than in the control group. There were no between-group differences in lung function, C-reactive protein
or length of hospital stay. Conclusion: The improvement in functional outcomes after an inpatient
rehabilitation programwas greater than the improvement after standard respiratory physiotherapy. The
exercise training program led to greater beneﬁts in functional capacity, peripheral muscle strength,
dyspnoea and quality of life. Registration: ClinicalTrials.gov, NCT02103400 [Jose´ A, Dal Corso S (2016)
Inpatient rehabilitation improves functional capacity, peripheral muscle strength and quality of
life in patients with community-acquired pneumonia: a randomised trial. Journal of Physiotherapy
62: 96–102]
 2016 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Community-acquired pneumonia is a highly prevalent adverse
health condition with a high mortality rate. It involves substantial
treatment costs and has signiﬁcant social impact worldwide.1
Patients who are hospitalised for community-acquired pneumonia
experience a decline in functional capacity,2–4 which is associated
with higher rates of re-hospitalisation and death,3,4 as well as
reductions in both peripheral muscle strength and quality of life.2
Moreover, such patients can endure a long period before the
complete remission of symptoms and the return to previous
activities of daily living.5
Although widely employed in clinical practice,6 the current
physiotherapeutic approach for patients with community-ac-
quired pneumonia, which focuses on airway clearance, is nothttp://dx.doi.org/10.1016/j.jphys.2016.02.014
1836-9553/ 2016 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/4.0/).supported by evidence7–10 and the main guidelines for the
management of this condition do not recommend it.1 In patients
who are hospitalised for acute exacerbations of chronic obstructive
pulmonary disease (COPD), an inpatient rehabilitation program
leads to some immediate improvements in functional capacity,
quality of life, peripheral muscle strength, exercise tolerance,11,12
anxietyanddepression.13However, the recentpublicationof amajor
study by Greening and colleagues has indicated that very early
exercise-based rehabilitation commenced during hospitalisation
may reduce uptake of pulmonary rehabilitation and increase
mortality after discharge.14 Interpreting this study in the light of
the existing evidence suggests that for patients who are hospitalised
for acute exacerbations of COPD, pulmonary rehabilitation immedi-
ately after dischargemay bemore beneﬁcial overall than commenc-
ing the exercise-based rehabilitation during hospitalisation.15.V. This is an open access article under the CC BY-NC-ND license (http://
Research 97In patients who are hospitalised for community-acquired pneumo-
nia, earlymobilisationhasbeenappliedonly inone large study, but it
was poorly described.16 Therefore, in these patients, the effects of
aerobic and resistance training on functional capacity, peripheral
muscle strength and quality of life require thorough investigation
during hospitalisation. Considering the high prevalence and
treatment costs of community-acquired pneumonia, its social
impact and the scarcity of evidence to support standard respiratory
physiotherapy for such patients, it is crucial to investigatewhether a
physical training program can lead to better recovery of functional
capacity at discharge from the hospital.
Therefore, the research question for this randomised trial was:
Among people who are hospitalised for community-acquired
pneumonia, does an inpatient exercise-based rehabilitation
program improve functional outcomes, symptoms, quality of life
and length of hospital stay more than a respiratory physiotherapy
regimen?
Method
Design
This study was a randomised trial, with concealed allocation,
blinding of assessors of some outcomes and intention-to-treat
analysis. Patients who were hospitalised for community-acquired
pneumonia were randomly assigned to receive either physical
exercise training (experimental group) or respiratory physiother-
apy (control group). After eligible patients were advised regarding
the study and consented to participate, they were randomly
allocated to one of the two groups. Upcoming random allocations[(Figure_1)TD$FIG]Day 10 
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Figure 1. Design and ﬂow of participants through the trial.
BMI = body mass index, COPD = chronic obstructive pulmonary disease, CRP = C-reactiv
Dyspnoea Scale, SF-36 = Short Form 36 questionnaire.were concealed in opaque, sealed envelopes that had been
prepared by a researcher who was not involved in the recruitment
or assessment of the participants. Data were obtained before
randomisation and 1 day after the 8-day intervention period. The
length of the hospital stay was also recorded for all participants
(Figure 1).
Participants, therapists and centre
The inclusion criteria for participation in the study were: being
aged > 18 years, having a diagnosis of community-acquired
pneumonia,1 being hospitalised for < 48 hours, and having
adequate awareness and independent ambulation. The exclusion
criteria were: being unwilling to participate, having cognitive
impairment, having osteoarticular disorders, and having other
acute or chronic respiratory diseases. The researchers in the study
applied the interventions. This study was conducted at Mandaqui
Hospital, which is a tertiary hospital in Sa˜o Paulo, Brazil.
Interventions
Control group
Participants allocated to the control group received standard
respiratory physiotherapy in daily 50-minute sessions for 8 days;
this involved secretion removal, breathing exercises and walking.
The secretion removal techniques were percussion and vibrocom-
pression in side lying for 10 minutes on each side, during and after
which the participant was instructed to perform voluntary
coughing and hufﬁng to expectorate secretions until achieving a
dry cough.17Control group   
•bronchial cleaning  
•respiratory exercises  
• free walking 
•1 session daily   
x 8 days 
Withdrawn  
• diagnosis 
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(n = 1) 
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(n = 1) 
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 of stay in hospital 
                                       (n = 17) 
e protein, ISWT = incremental shuttle walk test, MRC = Medical Research Council
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They included diaphragmatic breathing exercises (three sets of
10 repetitions with a 1-minute rest period between sets) and
inspiratory exercise with maximum inspiration and maximum
inspiratory pause (three sets of 10 repetitions with a 1-minute rest
period between sets).17 Walking was self-paced with a prescribed
duration of 10 minutes.
Experimental group
The participants allocated to the experimental group received
physical training in daily 50-minute sessions for 8 days; this
involved warm-up, stretching, resistance exercises for peripheral
muscles and aerobic walking training.
The warm-up involved active movements of the upper and
lower limbs for approximately 5 minutes. Stretching targeted the
pectoralis major, latissimus dorsi, trapezius, quadriceps femoris
and hamstring muscles. Participants held each stretch for
30 seconds and stretched for approximately 5 minutes in total.
Peripheral muscle strengthening exercises were performed for
approximately 25 minutes. The exercises were performed with
three sets of eight repetitions with a 1-minute rest period between
sets for both limbs simultaneously using an elastic banda. The
targeted muscles were biceps brachii, deltoids, quadriceps femoris
and hamstrings. The initial workload was 70% of maximum
peripheral muscle strength.18 At the end of each set, dyspnoea and
fatigue were measured using the Borg scale,19 with participants
aiming to score between 4 and 6 at the end of the three sets. If the
fatigue score was below this level, the workload was increased by
exchanging the elastic band for one more resistant, and if above
this level, the workload was decreased.
Aerobic training was performed in a ﬂat corridor that was 10 m
long. Participants walked for 15 uninterrupted minutes, with their
speed guided by the auditory recording of the endurance shuttle
walk test20 set at a speed corresponding to 70% of the speed
reached on the incremental shuttle walk test (ISWT).21 If the
participant was unable to tolerate this time or exhibited a drop in
pulse oxygen saturation (SpO2) < 84%, he or she was allowed to
rest on a chair, at which point the timer was paused. Upon feeling
capable of proceeding, the participant continued to walk until
completing the entire 15 minutes. Adjustments in the training
intensity were made according to symptoms (dyspnoea and
fatigue between 4 and 6 on the Borg scale)19 and/or 70% of the
predicted maximum heart rate, which was established using
Karvonen’s equation.22 If a participant reported a dyspnoea score<
4 and/or the heart rate remained below the rate established by
Karvonen’s equation, the speed of the walk was increased the
following day, and if dyspnoea was > 6 and/or the heart rate was
above the rate established in the equation, the speed of the walk
was diminished the following day.
Outcome measures
All evaluations were conducted on the ﬁrst and tenth days of
the study (Figure 1). The data that were collected to characterise
the participants at baseline included age, gender, body mass index
and the CURB-65 score, which is a tool for predicting risk of death
from community-acquired pneumonia.23 [6_TD$DIFF]
Primary outcome
Functional exercise capacity was measured using the Glittre
Activities of Daily Living test,24 which consists of a set of functional
activities (eg, rising from a chair, walking, stairs, lifting and
bending). The participant performs the sequence of activities ﬁve
times as quickly as possible. Each participant performed the entire
test twice, and the main outcome was the better time taken to
complete ﬁve laps.
Secondary outcomes
Exercise capacity was measured using the ISWT [3_TD$DIFF], performed as
previously described.21 [7_TD$DIFF] Two tests were performed on the sameday, and the longer distance that was walked was used for the
analysis.
Peripheral muscle strength was measured using a
dynamometerb. The peak of isometric contraction was recorded
for the biceps brachii, deltoid, quadriceps femoris and hamstring
muscles. Three maximum isometric contractions were performed,
and the highest value was considered in the analysis.25
Quality of life was measured using the Short Form 36 question-
naire (SF-36),26 which has eight subscales: physical functioning,
physical role functioning, pain, general health state, vitality, social
role functioning, emotional role functioning, and mental health.
The score for each subscale ranges from 0 to 100 points, with
higher scores denoting better quality of life.
Dyspnoea was measured using the Medical Research Council
scale,27 [8_TD$DIFF] which is composed of ﬁve activities on which breathless-
ness is scored from 1 to 5. Higher scores denote greater limitations
to activities of daily living.
Pulmonary function was measured using a portable
spirometerc. The technical procedures were based on Brazilian
guidelines.28 The data were expressed as absolutes and percen-
tages of predicted values for the forced expiratory volume in one
second (FEV1) and the forced vital capacity (FVC).
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Blinded assessors determined the following outcomes: inﬂam-
mation was measured based on C-reactive protein (CRP) using a
venous blood sample. The respiratory physician, who was blinded
to the participants’ group allocation, decided on the length of
hospital stay. Hospital records were used to conﬁrmwhether there
were any deaths before discharge.
The safety of the interventions was evaluated based on the
observation and occurrence of adverse events such as nausea,
lightheadedness, signiﬁcant dyspnoea, extreme fatigue, chest pain,
arrhythmia, syncope, altered consciousness or severe desaturation
(SpO2  80%).
Data analysis
The sample size was calculated in relation to the Glittre
Activities of Daily Living test24 as themain outcome andwas based
on results obtained from a pilot studywith ﬁve participants in each
group. An effect size of 1.3 was estimated from a mean time of
213 seconds to perform the Glittre Activities of Daily Living test in
the control group and 153 seconds for the experimental group,
with a SD within each group of 45 seconds. Unequal treatment
allocation (2:1)was assumed due to ethical reasons formaximising
participants’ exposure to the experimental group. Assuming an a
error of 0.05, a b error of 0.20 and an allocation ratio of 2:1, the
sample size was determined to be 24 participants in the
intervention group and 12 in the control group.
The Shapiro-Wilk test was used to determine the distribution
(normal or non-normal) of the data. Baseline characteristics were
summarised using mean (SD) for parametric data and median
(IQR) for non-parametric data. The continuous outcome data were
analysed as mean (SD) of two groups, mean (SD) within-group
difference and mean (95% CI) between-group difference. The
standardised effect size was calculated using Cohen’s d. Pearson’s
correlation coefﬁcients were calculated to determine the strength
of correlations between variables. The datawere analysed based on
intention-to-treat analysis. A p-value < 0.05 was considered
signiﬁcant.
Results
Compliance with the study protocol
The target sample size in the registered protocol was
30 participants. This was based on a calculation using the
difference to be detected from a study by Skumlien and
colleagues24 and the SD from a study by Jose´ and colleagues.2
When the results of our pilot study became available early in the
Table 1
Baseline characteristics of participants.
Characteristic Randomised (n=49)
Exp (n=32) Con (n=17)
Age (yr), mean (SD) 51 (21) 59 (18)
Gender, n males (%) 17 (53) 10 (59)
Body mass index, (kg/m2), mean (SD) 23 (4) 25 (6)
CURB-65, median (IQR) 1 (1 to 1) 1 (1 to 2)
Exp=experimental group, Con= control group.
Research 99conduct of the present study, the sample size calculation outlined
in the Data analysis section, above, was considered to be the better
choice for the present study. This exceeded the registered target
sample size.
One registered outcome measure, Tumour Necrosis Factor-
alpha (TNFa), was not reported.[10_TD$DIFF] In principle, the analysis of TNFa
should have been carried out in the hospital. However, the hospital
carried out the analysis on seven participants and did not allow
further collection due to the high cost of the test. The limited data
are available from the authors on request.
Flow of participants through the study
Of the 65 patients admitted with an initial diagnosis of
community-acquired pneumonia during the study recruitment
period, 14were excluded based on the eligibility criteria (Figure 1).
A further two participants were [11_TD$DIFF]withdrawn after randomisation
because their diagnosis of community-acquired pneumonia
changed during reassessment by a physician; they were not
included in the intention-to-treat analysis. Therefore, the study
reports data on 49 participants: 32 in the experimental group and
17 in the control group. Five participants in the experimental group
and one in the control group were discharged before the scheduled
post-intervention reassessment on Day 10, but these participants
could be included in the analysis of length of hospital stay.
A further two participants in the control group withdrew from theTable 3
Mean (SD) of groups,mean (SD) differencewithin groups, andmean (95% CI) difference be
36) questionnaire.
Domains Groups
Day 1 Day
Exp (n=32) Con (n=17) Exp (n=32)
Physical functioning 52 (20) 52 (26) 80 (21)
Physical role functioning 37 (31) 40 (37) 58 (30)
Pain 41 (22) 37 (26) 55 (23)
General health state 58 (16) 56 (23) 70 (12)
Vitality 48 (13) 48 (20) 69 (16)
Social role functioning 62 (24) 43 (21) 68 (22)
Emotional role functioning 43 (35) 22 (29) 57 (32)
Mental health 53 (20) 49 (18) 60 (19)
Exp=experimental group, Con= control group.
Table 2
Mean (SD) of groups, mean (SD) difference within groups and mean (95% CI) difference
and inﬂammation.
Outcomes Groups
Day 1
Exp (n=32) Con (n=17) Exp (n=32
Glittre ADL Test (s) 229 (86) 223 (52) 177 (93)
Incremental Shuttle Walk Test (m) 355 (126) 313 (91) 517 (184)
Biceps brachii strength (kgf) 12.9 (4.7) 12.9 (5.6) 15.7 (4.8)
Deltoids strength (kgf) 5.4 (2.0) 5.3 (2.5) 7.6 (2.5)
Quadriceps strength (kgf) 25.6 (5.7) 24.2 (8.3) 32.5 (8.5)
Hamstrings strength (kgf) 15.5 (5.7) 14.4 (5.8) 21.4 (7.6)
MRC Dyspnoea scale (1 to 5) 3.1 (1.1) 2.5 (0.9) 1.6 (0.9)
C-reactive protein (mg/l) 14 (14) 11 (13) 5 (7)
ADL=activities of daily living, Con= control group, Exp=experimental group, MRC=Mestudy due to the constraints of their medical management
(Figure 1). All participants permitted their length of stay to be
recorded.
The baseline characteristics of the groups were similar. These
data are presented in Table 1[12_TD$DIFF] and the ﬁrst two data columns of
Table 2, Table 3 and Table 4. Individual participant data are
presented in Table 5 on the eAddenda.
Effect of interventions
Primary outcome
Functional exercise capacity, as measured by the Glittre
Activities of Daily Living test, improved by a mean of 52 seconds
(SD 40) in the experimental group, whereas the control group
improved by a mean of 12 seconds (SD 26). This was a statistically
signiﬁcant difference (MD39 seconds, 95% CI 20 to 59), as shown in
Table 2. When calculated as a standardised effect size, the
between-group difference of 39 seconds equated to a Cohen’s d
of 1.19.
Secondary outcomes
The improvement in functional capacity, as evaluated by the
distance walked on the ISWT, was signiﬁcantly greater in the
experimental group than in the control group (MD 130 m, 95% CI
77 to 182). When calculated as a standardised effect size, the
between-group difference equated to a Cohen’s d of 1.39. No
signiﬁcant between-group differences occurred in the variables
monitored during the ISWT: heart rate, percentage of predicted
maximal heart rate, SpO2 and Borg dyspnoea and fatigue scales
(data not shown). The SpO2 during the aerobic training did not
show any desaturation < 84%, as outlined in the Methods section.
All muscles that were analysed demonstrated mean improve-
ment in strength in the experimental group and mean deteriora-
tion in the control group, as presented in Table 2. The between-
group difference in change in strength was statistically signiﬁcant
for all fourmuscle groups. The between-group differences in change
in strengthwere: 3.5 kgf for biceps brachii (Cohens’d = 0.76); 2.2 kgftween groups for health-related quality of life assessed using the Short Form 36 (SF-
Difference within groups Difference between groups
10 Day 10 minus Day 1 Day 10 minus Day 1
Con (n=17) Exp Con Exp minus Con
66 (20) 28 (22) 14 (24) 13 (1 to 28)
45 (36) 21 (28) 5 (26) 16 (–1 to 32)
43 (20) 14 (16) 6 (28) 8 (–8 to 23)
63 (22) 12 (13) 7 (18) 5 (–5 to 15)
68 (15) 21 (21) 20 (23) 0 (–13 to 14)
54 (24) 7 (17) 11 (14) –5 (–14 to 5)
38 (39) 15 (21) 16 (29) –2 (–18 to 15)
53 (19) 7 (9) 4 (17) 3 (–6 to 12)
between groups for functional capacity tests, peripheral muscle strength, dyspnoea
Difference within groups Difference between groups
Day 10 Day 10 minus Day 1 Day 10 minus Day 1
) Con (n=17) Exp Con Exp minus Con
211 (46) –52 (40) –12 (26) –39 (–59 to –20)
346 (94) 162 (110) 33 (71) 130 (77 to 182)
12.2 (4.6) 2.7 (2.5) –0.7 (4.8) 3.5 (0.9 to 6.0)
5.3 (2.4) 2.2 (1.8) 0.0 (1.5) 2.2 (1.2 to 3.2)
22.6 (6.7) 6.9 (6.1) –1.6 (5.5) 8.5 (4.6 to 11.6)
13.9 (4.2) 5.9 (4.7) –0.5 (3.5) 6.5 (4.0 to 8.8)
1.9 (0.7) –1.5 (1.1) –0.6 (0.7) –0.9 (–1.4 to –0.4)
5 (5) –9 (14) –7 (13) –2 (–10 to 6)
dical Research Council.
Table 4
Mean (SD) of groups, mean (SD) difference within groups, and mean (95% CI) difference between groups for lung function.
Outcome Groups Difference within groups Difference between groups
Day 1 Day 10 Day 10 minus Day 1 Day 10 minus Day 1
Exp (n=32) Con (n=17) Exp (n=32) Con (n=17) Exp Con Exp minus Con
FEV1 (l) 2.05 (0.66) 2.20 (0.86) 2.21 (0.63) 2.15 (0.59) 0.16 (0.26) –0.06 (0.62) 0.21 (–0.11 to 0.54)
FEV1 (% pred) 69 (11) 75 (12) 74 (10) 75 (12) 6 (8) 1 (15) 5 (–3 to 13)
FVC (l) 2.55 (0.74) 2.66 (0.97) 2.71 (0.65) 2.67 (0.76) 0.16 (0.29) 0.01 (0.49) 0.15 (–0.12 to 0.42)
FVC (% pred) 69 (11) 71 (10) 74 (8) 73 (9) 5 (8) 2 (11) 3 (–3 to 9)
Con= control group, Exp=experimental group, FEV1 = forced expiratory volume in one second, FVC= forced vital capacity, % pred=percentage of the predicted value.
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d = 1.46); and 6.4 kgf for hamstrings (Cohen’s d = 1.54).
The domain ‘physical functioning’ of the SF-36 quality of life
questionnaire improved signiﬁcantly more in the experimental
group than in the control group (MD 14 points, 95% CI 1 to 28,
Cohen’s d = 0.48). None of the other domains of the SF-36 showed
statistically signiﬁcant effects (Table 3).
Both groups showed an improvement on average in the severity
of dyspnoea, as measured on the Medical Research Council scale
during the 10 days of the study. However, the experimental group
showed signiﬁcantly greater improvement (MD 0.9 points, 95% CI
0.4 to 1.4, Cohen’s d = 0.98).
Pulmonary function was reduced to a similar degree compared
to predicted values in both groups (Table 4). After the interven-
tions, no substantial change in pulmonary function was detected.
Both groups showed a reduction on average in CRP during the
10 days of the study. The amount of reduction was similar in the
two groups. No correlationswere found between CRP and the other
variables studied. Moreover, the change in CRP was not correlated
with peripheral muscle strength or improvement in the perfor-
mance of the functional capacity tests.
All participants survived long enough to be discharged from the
hospital. The type of treatment didnot signiﬁcantly inﬂuence length
of stay inhospital:median12days (IQR10 to18) in theexperimental
group andmedian 13 days (IQR 11 to 25) in the control group. None
of the adverse events listed in the Methods section were identiﬁed
during the application of the allocated interventions.
Discussion
It is believed that this is the ﬁrst study to investigate the effects
of an inpatient rehabilitation program on patients with communi-
ty-acquired pneumonia by comparing themwith those of standard
respiratory physiotherapy. The results were superior to those of
standard respiratory physiotherapy.
Although it is common practice,6 [9_TD$DIFF] there is no evidence to support
the routine use of standard respiratory physiotherapy in patients
who are hospitalised for community-acquired pneumonia. A
randomised clinical trial examined intervention for pneumonia
that included postural drainage, percussion, thoracic vibration and
positive pressure, but failed to demonstrate changes in fever, the
extent of radiographic impairment, length of hospital stay, or
mortality.7 These results are in line with the results of another
study of techniques such as postural drainage, external support for
breathing, percussion and vibration in pneumonia.8 There was no
overall effect and in younger patients, smokers and patients with
interstitial pneumonia speciﬁcally, the intervention led to an
increase in the duration of fever and length of hospital stay.8 A
systematic review of adjunctive therapies for patients hospitalised
for community-acquired pneumonia has shown that clinical trials
with such respiratory physiotherapy techniques are scarce and do
not provide evidence of beneﬁts from their routine use in these
patients.9
In a recent meta-analysis, Yang et al10 compared standard
respiratory physiotherapy to usual care and found no signiﬁcant
differences regarding mortality, the resolution of the disease,
improvement in chest radiography or healing time. The same wasobservedwhen comparing the active cycle of breathing techniques
with usual care, including no difference regarding hospitalisation
length, duration of antibiotic therapy, mean duration of sputum
production or inpatient sputum weight.
As previous studies have demonstrated that standard
respiratory physiotherapy has no impact on clinical measures
of the resolution of pneumonia, it is interesting to observe
(albeit without a no-intervention control group for comparison)
the change in functional outcomes in the group that received
respiratory therapy in the present study. This group did not
show substantial improvement in the distance walked on the
ISWT. There is no minimum clinically important difference
established for the ISWT speciﬁcally for patients hospitalised for
community-acquired pneumonia, but the magnitude of the
average improvement observed in this group was inferior to that
found after an outpatient rehabilitation program for both
patients with non-cystic ﬁbrosis bronchiectasis (37 m)30 and
with COPD (48 m).31 The same lack of substantial improvement
was observed in the group that received respiratory therapy
for the Glittre Activities of Daily Living test, where again the
best estimate of the minimum clinically important difference
is indirect because it comes from patients with COPD
(53 seconds).24
No association was found between hospital length of stay and
type of treatment. However, in a study conducted byMundy et al, a
reduction in hospital length of stay was found when early
mobilisation was performed.16 This divergence may have occurred
because the hospital length of stay in the present study depended
on factors other than clinical criteria, such as the economic status
of the patient, the ability to afford antibiotic therapy, cognition,
capacity to self-medicate correctly and administrative aspects of
the hospital such as availability of hospital beds.
All participants were discharged, so there was no association
between mortality and the type of treatment. This was due to the
low severity of cases, as represented by the low CURB-65,
corresponding to prognosis of a low degree of lethality.23 A
previous study had demonstrated that early mobilisation did not
interfere in the mortality of these patients, with no change in the
re-hospitalisation rate within a 90-day period.16
No important complications occurred due to the intervention
protocols, indicating that the protocols are safe and could be
performed on patients with community-acquired pneumonia
whose characteristics are similar to those of the present sample.
Physical exercise with early mobilisation of hospitalised patients
has previously been performed and appears to be safe for patients
with COPD,11–13 asthma,32 interstitial lung disease33 and commu-
nity-acquired pneumonia.16 However, as discussed above, exer-
cise-based rehabilitation commenced during hospitalisation for
COPD exacerbation may reduce uptake of pulmonary rehabilita-
tion and increase mortality after discharge,14 so pulmonary
rehabilitation immediately after discharge may be more beneﬁcial
for patients with COPD.15
Previous studies have demonstrated that short-term hospita-
lisation reduces functional capacity, even in patients who are not
bedridden, regardless of age or initial functional status.34 In a
recent study, a decline in functional capacity as well as reductions
in both peripheral muscle strength and quality of life2 were
demonstrated in patients hospitalised for community-acquired
Research 101pneumonia. Therefore, interventions tominimise such declines are
crucial for these patients.
Mundy et al evaluated the effects of early mobilisation
performed by nurses on 456 patients who were hospitalised for
community-acquired pneumonia and found that hospitalisation
length and costswere reduced,with no adverse events.16 However,
this intervention was poorly described and the control group did
not receive any kind of standard respiratory physiotherapy. The
present study is the ﬁrst to demonstrate the relative effects of a
physical training program on functional capacity for hospitalised
patients with community-acquired pneumonia. The aerobic and
resistance training provided amore effective recovery of functional
capacity than standard respiratory physiotherapy.
The loss of peripheral muscle strength is a common adverse
change in hospitalised patients, even during short periods of
hospitalisation.34 The interventions performed in the present
study led to a signiﬁcant increase in peripheral muscle strength of
the exercised muscles, whereas no such increase occurred in the
control group. The training to improve peripheral muscle strength
was performed with elastic bands due to the difﬁculty in
transporting and storing weights in a hospital setting with limited
space. Elastic bands are a low-cost, highly practical alternative
with no need formore expensive equipment, which hospitals often
cannot provide, and are as effective as other recources.35
The evaluation of dyspnoea using the Medical Research Council
scale revealed a greater reduction in the experimental group than
in the control group, although both groups improved substantially.
However, if a reduction of 0.58 is considered clinically signiﬁcant
for theMedical Research Council scale,36 this reduction occurred in
both groups. Besides the improvement in the clinical status and the
resolution of the lung disease, it is possible that the 10-minute
walk in the control group as well as the aerobic and resistance
training in the experimental group both led to a lower sensation of
dyspnoea upon discharge from the hospital.
The magnitude of change in CRP was similar in both groups,
suggesting that the common management or natural recovery
(rather than the randomised interventions) determined the
reduction in CRP. The association between CRP and functional
capacity was also investigated in the present study, but was not
signiﬁcant. This was likely due to the low severity of community-
acquired pneumonia, since previous studies with severe patients
with high levels of CRP found such an association, along with a
worse prognosis. Moreover, a high level of CRP upon admission to
the hospital, the maintenance of this level after treatment and a
small reduction in comparison to the initial level have also been
associatedwith a worse prognosis as well as greater morbidity and
mortality rates.37,38
A limitation of the present study was that the researchers who
evaluated the Glittre Activities of Daily Living test, ISWT, quality of
life, dyspnoea, peripheralmuscle strength and spirometrywere the
same as those who performed the therapeutic interventions.
However, the evaluations were standardised with written guide-
lines to minimise the potential for bias from unblinded assessors.
Furthermore, the assessors were blinded for some key study
outcomes such as CRP, length of stay and outcome (death or
hospital discharge).
In summary, this study identiﬁed signiﬁcant improvements in
functional capacity, peripheral muscle strength, dyspnoea and
quality of life with inpatient exercise rehabilitation as opposed to
respiratory interventions. It is believed that these beneﬁts, in
conjunction with other evidence about the beneﬁts of inpatient
exercise in this population,16 are sufﬁcient to recommend the use
of an inpatient rehabilitation program – especially where the
current routine treatment for these patients is respiratory
physiotherapy techniques, since the latter lacks robust evidence
to support its routine use in this population. Given the unexpected
effects of inpatient exercise rehabilitation in COPD exacerba-
tions,14 however, further research should investigate the effects of
the intervention of people with community-acquired pneumonia
after discharge from hospital.What is already known on this topic: People who are
hospitalised for community-acquired pneumonia experience
a decline in functional capacity that is associated with higher
rates of re-hospitalisation and death. Existing evidence does
not support the use of respiratory techniques, although these
remain standard practice in some hospitals.
What this study adds: Among people who are hospitalised
for community-acquired pneumonia, an exercise training pro-
gram led to greater benefits in functional capacity, peripheral
muscle strength, dyspnoea and quality of life than a regimen
that included respiratory techniques and self-paced walking.Footnotes: aThera BandTM, The Hygenic Corporation, Akron,
Ohio, USA. b [13_TD$DIFF][14_TD$DIFF] Kratos, Sa˜o Paulo, Brazil.[15_TD$DIFF] c[16_TD$DIFF] Pony, Cosmed, Rome, Italy.
eAddenda: Table 5 can be found online at doi:10.1016/j.jphys.
2016.02.014.
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